Literature DB >> 34634786

Decreased Triglyceride and Increased Serum Lipoprotein Lipase Levels Are Correlated to Increased High-Density Lipoprotein-Cholesterol Levels after Laparoscopic Sleeve Gastrectomy.

Masahiro Ohira1, Yasuhiro Watanabe2, Takashi Yamaguchi2, Hiroki Onda2, Shuhei Yamaoka2, Kazuki Abe2, Shoko Nakamura2, Sho Tanaka2, Naoyuki Kawagoe1, Taiki Nabekura3, Takashi Oshiro3, Daiji Nagayama2,4, Ichiro Tatsuno2,5, Atsuhito Saiki2.   

Abstract

INTRODUCTION: Laparoscopic sleeve gastrectomy (LSG) significantly increases high-density lipoprotein cholesterol (HDL-C) and lipoprotein lipase (LPL) in pre-heparin serum (pre-heparin LPL levels). LPL is a regulator of serum triglyceride (TG) and HDL-C production; this may be the mechanism for HDL-C increase after LSG. This study aimed to elucidate the mechanism of increase in HDL-C levels by examining the relationship between changes in serum HDL-C levels and LPL after LSG.
METHODS: We retrospectively reviewed 104 obese patients, who underwent LSG and were followed up for 12 months. We analyzed the relationship between changes in serum HDL-C levels and various clinical parameters after LSG.
RESULTS: A significant decrease was observed in the patients' BMI and serum TG levels after LSG. Conversely, HDL-C levels and pre-heparin LPL levels were significantly increased after LSG. Simple linear regression showed that changes in HDL-C levels were significantly correlated with total weight loss percentage, change in TG levels, abdominal fat areas, and pre-heparin LPL levels. Additionally, the multiple regression model revealed that a decrease in TG levels and an increase in pre-heparin LPL levels were correlated with increased HDL-C levels after LSG. DISCUSSION/
CONCLUSION: These results show that a decrease in TG levels and an increase in LPL are mechanisms for increased HDL-C levels after LSG.
© 2021 The Author(s). Published by S. Karger AG, Basel.

Entities:  

Keywords:  High-density lipoprotein cholesterol; Laparoscopic sleeve gastrectomy; Lipoprotein lipase; Obesity; Triglyceride

Mesh:

Substances:

Year:  2021        PMID: 34634786      PMCID: PMC8739375          DOI: 10.1159/000519410

Source DB:  PubMed          Journal:  Obes Facts        ISSN: 1662-4025            Impact factor:   3.942


  56 in total

1.  Bariatric Surgery versus Intensive Medical Therapy for Diabetes - 5-Year Outcomes.

Authors:  Philip R Schauer; Deepak L Bhatt; John P Kirwan; Kathy Wolski; Ali Aminian; Stacy A Brethauer; Sankar D Navaneethan; Rishi P Singh; Claire E Pothier; Steven E Nissen; Sangeeta R Kashyap
Journal:  N Engl J Med       Date:  2017-02-16       Impact factor: 91.245

2.  Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease.

Authors:  G J Miller; N E Miller
Journal:  Lancet       Date:  1975-01-04       Impact factor: 79.321

3.  Enhancement of preheparin serum lipoprotein lipase mass by bezafibrate administration.

Authors:  M Totsuka; Y Miyashita; Y Ito; H Watanabe; T Murano; K Shirai
Journal:  Atherosclerosis       Date:  2000-11       Impact factor: 5.162

4.  Pre-heparin plasma lipoprotein lipase mass: correlation with intra-abdominal visceral fat accumulation.

Authors:  J Kobayashi; K Saito; I Fukamachi; K Taira; K Takahashi; H Bujo; Y Saito
Journal:  Horm Metab Res       Date:  2001-07       Impact factor: 2.936

5.  Pioglitazone decreases plasma angiotensin II concentration in type 2 diabetes.

Authors:  Atsuhito Saiki; Masahiro Ohira; Kei Endo; Nobukiyo Koide; Tomokazu Oyama; Takeyoshi Murano; Yoh Miyashita; Kohji Shirai
Journal:  J Atheroscler Thromb       Date:  2010-05-13       Impact factor: 4.928

6.  Insulin resistance affects the regulation of lipoprotein lipase in the postprandial period and in an adipose tissue-specific manner.

Authors:  D Panarotto; P Rémillard; L Bouffard; P Maheux
Journal:  Eur J Clin Invest       Date:  2002-02       Impact factor: 4.686

7.  Lipoprotein lipase mass and activity in severe hypertriglyceridemia.

Authors:  J Kobayashi; H Hashimoto; I Fukamachi; J Tashiro; K Shirai; Y Saito; S Yoshida
Journal:  Clin Chim Acta       Date:  1993-07-16       Impact factor: 3.786

8.  Changes in plasma high-density lipoprotein cholesterol concentration after weight reduction in grossly obese subjects.

Authors:  D A Streja; E Boyko; S W Rabkin
Journal:  Br Med J       Date:  1980-09-20

9.  Impaired activation of adipocyte lipolysis in familial combined hyperlipidemia.

Authors:  S Reynisdottir; M Eriksson; B Angelin; P Arner
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

Review 10.  Obesity and Type 2 Diabetes: Two Diseases with a Need for Combined Treatment Strategies - EASO Can Lead the Way.

Authors:  Deborah R Leitner; Gema Frühbeck; Volkan Yumuk; Karin Schindler; Dragan Micic; Euan Woodward; Hermann Toplak
Journal:  Obes Facts       Date:  2017-10-12       Impact factor: 3.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.